Drugs for smoking cessation

BMJ (Online)

Volumn 352, Issue , 2016, Pages

  Hartmann Boyce, Jamie ^a   Aveyard, Paul ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CYTISINE; NICOTINE; NICOTINE PATCH; VARENICLINE; DOPAMINE UPTAKE INHIBITOR; NICOTINE GUM; NICOTINIC AGENT;

ACUPUNCTURE; ADULT; CASE REPORT; CONSULTATION; DOPAMINERGIC TRANSMISSION; DRUG EFFICACY; ELECTRONIC CIGARETTE; FEMALE; HUMAN; HYPNOSIS; MENOPAUSAL SYNDROME; MIDDLE AGED; NICOTINE REPLACEMENT THERAPY; NOTE; OBSERVATIONAL STUDY; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; TOBACCO DEPENDENCE; CONTRAINDICATIONS; DRUG MONITORING; PRACTICE GUIDELINE; PREGNANCY; PREVENTION AND CONTROL; PROCEDURES; TOBACCO USE DISORDER;

BUPROPION; DOPAMINE UPTAKE INHIBITORS; DRUG MONITORING; FEMALE; HUMANS; MIDDLE AGED; NICOTINIC AGONISTS; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION PRODUCTS; TOBACCO USE DISORDER; VARENICLINE;

EID: 84960146010     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i571     Document Type: Note

References (27)

1. Stead LF, Perera R, Bullen C, et al. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst Rev 2012;11:CD000146.23152200.
2. Cahill K, Stead LF, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev 2012;4:CD006103.22513936.
3. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database Syst Rev 2014;1:CD000031.24402784.
4. Stapleton J. Cigarette smoking prevalence, cessation and relapse. Stat Methods Med Res 1998;7:187-203. doi:10.1191/096228098671391775. 9654641.
5. Etter JF, Stapleton JA. Nicotine replacement therapy for long-term smoking cessation: a meta-Analysis. Tob Control 2006;15:280-5. doi:10.1136/tc.2005.015487. 16885576.
6. Cahill K, Stevens S, Perera R, Lancaster T. Pharmacological interventions for smoking cessation: an overview and network meta-Analysis. Cochrane Database Syst Rev 2013;5:CD009329.23728690.
7. Joseph AM, Norman SM, Ferry LH, et al. The safety of transdermal nicotine as an aid to smoking cessation in patients with cardiac disease. N Engl J Med 1996;335:1792-8. doi: 10.1056/NEJM199612123352402. 8943160.
8. Singh S, Loke YK, Spangler JG, Furberg CD. Risk of serious adverse cardiovascular events associated with varenicline: a systematic review and meta-Analysis. CMAJ 2011;183:1359-66. doi:10.1503/cmaj.110218. 21727225.
9. Prochaska JJ, Hilton JF. Risk of cardiovascular serious adverse events associated with varenicline use for tobacco cessation: systematic review and meta-Analysis. BMJ 2012;344:e2856. doi:10.1136/bmj.e2856. 22563098.
10. National Institute for Health and Care Excellence. Smoking cessation services. NICE, 2008.
11. Tobacco Use and Dependence Guideline Panel. Treating tobacco use and dependence: 2008 update. Department of Health and Human Services, 2008.
12. Shahab L. Cost-effectiveness of pharmacotherapy for smoking cessation. National Centre for Smoking Cessation and Training (NCSCT), 2012. (available at http://www.ncsct.co. uk/usr/pub/B7-Cost-effectiveness-pharmacotherapy.pdf).
13. Woolacott NF, Jones L, Forbes CA, et al. The clinical effectiveness and cost-effectiveness of bupropion and nicotine replacement therapy for smoking cessation: a systematic review and economic evaluation. Health Technol Assess 2002;6:1-245. doi:10.3310/hta6160. 12269277.
14. Zimovetz EA, Wilson K, Samuel M, Beard SM. A review of cost-effectiveness of varenicline and comparison of cost-effectiveness of treatments for major smoking-related morbidities. J Eval Clin Pract 2011;17:288-97. doi:10.1111/j.1365-2753.2010.01439.x. 21029268.
15. Moore D, Aveyard P, Connock M, Wang D, Fry-Smith A, Barton P. Effectiveness and safety of nicotine replacement therapy assisted reduction to stop smoking: systematic review and meta-Analysis. BMJ 2009;338:b1024. doi:10.1136/bmj.b1024. 19342408.
16. Ebbert JO, Hughes JR, West RJ, et al. Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial. JAMA 2015;313:687-94. doi:10.1001/jama. 2015.280. 25688780.
17. Mills EJ, Wu P, Lockhart I, Wilson K, Ebbert JO. Adverse events associated with nicotine replacement therapy (NRT) for smoking cessation. A systematic review and meta-Analysis of one hundred and twenty studies involving 177,390 individuals. Tob Induc Dis 2010;8:8. doi:10.1186/1617-9625-8-8. 20626883.
18. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2012;9:CD010078.22972148.
19. Gibbons RD, Mann JJ. Varenicline, smoking cessation, and neuropsychiatric adverse events. Am J Psychiatry 2013;170:1460-7. doi:10.1176/appi.ajp.2013. 12121599. 24030388.
20. Thase ME, Haight BR, Johnson MC, et al. A randomized, double-blind, placebo-controlled study of the effect of sustained-release bupropion on blood pressure in individuals with mild untreated hypertension. J Clin Psychopharmacol 2008;28:302-7. doi:10.1097/JCP. 0b013e318172424e. 18480687.
21. Hajek P, McRobbie HJ, Myers KE, Stapleton J, Dhanji AR. Use of varenicline for 4 weeks before quitting smoking: decrease in ad lib smoking and increase in smoking cessation rates. Arch Intern Med 2011;171:770-7. doi:10.1001/archinternmed.2011.138. 21518946.
22. Lindson N, Aveyard P. An updated meta-Analysis of nicotine preloading for smoking cessation: investigating mediators of the effect. Psychopharmacology (Berl) 2011;214:579-92. doi:10.1007/s00213-010-2069-3. 21060996.
23. Ferguson SG, Gitchell JG, Shiffman S. Continuing to wear nicotine patches after smoking lapses promotes recovery of abstinence. Addiction 2012;107:1349-53. doi:10.1111/j. 1360-0443.2012.03801.x. 22276996.
24. Stead LF, Lancaster T. Combined pharmacotherapy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev 2012;10:CD008286.23076944.
25. White AR, Rampes H, Liu JP, Stead LF, Campbell J. Acupuncture and related interventions for smoking cessation. Cochrane Database Syst Rev 2014;1:CD000009.24459016.
26. Barnes J, Dong CY, McRobbie H, Walker N, Mehta M, Stead LF. Hypnotherapy for smoking cessation. Cochrane Database Syst Rev 2010;10:CD001008.20927723.
27. McRobbie H, Bullen C, Hartmann-Boyce J, Hajek P. Electronic cigarettes for smoking cessation and reduction. Cochrane Database Syst Rev 2014;12:CD010216.25515689.